NATA - Nucleic Acid Therapy Accelerator
Contact
View in org chart
Nick Lench
Executive Director
Laura Sepp - Lorenzino
Chief Scientific Officer, Intellia Therapeutics (us)
Shalini Andersson
Chief Scientist Of New Therapeutic Modalities And Head Of Oligonucleotide Discovery, Astrazeneca (sweden)
Anne Willis
Professor Of Toxicology And MRC Toxicology Unit Director, University Of Cambridge (uk)
Alison Smith
Vice President, Portfolio And Technology Delivery, GSK
Muthiah Manoharan
Senior Vice President Of Drug Innovation Chemistry, Alnylam (us)
Mark Cunningham
Head Of Operations
Peter Oliver
Head Of Biology
Remya R. Nair
Senior Researcher
+ 1 more
Current role